Results 121 to 130 of about 3,791 (213)

Analysis of clinical factors associated with incomplete standard protocol ¹⁷⁷Lu-DOTATATE treatment in neuroendocrine tumor patients. [PDF]

Jpn J Radiol
Sugawara S, Okamoto S, Go H, Ishii S, Ito H, Shiga T, Oriuchi N.   +6 more
europepmc   +1 more source

Dose Mapping After Endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a Single Measurement After 4 Days

Journal of Nuclear Medicine, 2018
H. Hänscheid, C. Lapa, A. Buck, M. Lassmann, R. Werner   +4 more
semanticscholar   +1 more source

Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome.

J Clin Endocrinol Metab, 2021
Zandee WT, Brabander T, Blažević A, Minczeles NS, Feelders RA, de Herder WW, Hofland J.   +6 more
europepmc   +1 more source

Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient with Treatment-Related Neuroendocrine Prostate Cancer with Urinary Retention and Rectal Obstruction: A Case Report. [PDF]

Yonago Acta Med
Yasukawa R, Kawamoto B, Muraoka K, Nakamura K, Honda M, Takenaka A.   +5 more
europepmc   +1 more source

Dosimetric implications of kidney anatomical volume changes in ¹⁷⁷Lu-DOTATATE therapy. [PDF]

EJNMMI Phys
Khan J, Rydèn T, Van Essen M, Svensson J, Grudzinski J, Bernhardt P.   +5 more
europepmc   +1 more source

Case of the Season: ¹⁷⁷Lu-DOTATATE Peptide Receptor Radiotherapy With Acute Dialysis Support in a Patient With Chronic Kidney Disease (CKD). [PDF]

Semin Roentgenol
Fitzpatrick KJ, Vicari M, Niedbala J, Frey KA, Dewaraja Y, Wong KK.   +5 more
europepmc   +1 more source

Evaluating auto-contouring accuracy in reduced CT dose images for radiopharmaceutical therapies: Denoising and evaluation of ¹⁷⁷Lu DOTATATE therapy dataset. [PDF]

J Appl Clin Med Phys
Yang HT, Ko KY, Yang CC.
europepmc   +1 more source

Tratamiento de tumores neuroendocrinos metastáticos con 177Lu-DOTATATE

Grado en ...
openaire   +1 more source

Outcome of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Progressive Metastatic Neuroendocrine Tumors from a Tertiary Care Center. [PDF]

Indian J Endocrinol Metab
Mathew D, Sunny SS, Benjamin J, John JR, Jebasingh FK, Georgy JT, Singh A, Oommen R.   +7 more
europepmc   +1 more source